Terms: = Liver cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
24 results:
1. Identification of ASF1A and HJURP by global H3-H4 histone chaperone analysis as a prognostic two-gene model in hepatocellular carcinoma.
Liu Y; Liu S; Jing R; Li C; Guo Y; Cai Z; Xi P; Dai P; Jia L; Zhu H; Zhang X
Sci Rep; 2024 Apr; 14(1):7666. PubMed ID: 38561384
[TBL] [Abstract] [Full Text] [Related]
2. Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma.
Kato H; Hayami S; Ueno M; Suzaki N; Nakamura M; Yoshimura T; Miyamoto A; Shigekawa Y; Okada KI; Miyazawa M; Kitahata Y; Ehata S; Hamamoto R; Yamaue H; Kawai M
Cancer Sci; 2024 Feb; 115(2):385-400. PubMed ID: 38082550
[TBL] [Abstract] [Full Text] [Related]
3. BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression.
Liu W; Wang S; Lin L; Zou R; Sun H; Zeng K; Wu Y; Li Y; Shigeaki K; Wang X; Wang C; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166974. PubMed ID: 38042310
[TBL] [Abstract] [Full Text] [Related]
4. Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells.
Li JY; Tian T; Han B; Yang T; Guo YX; Wu JY; Chen YS; Yang Q; Xie RJ
World J Gastroenterol; 2023 Sep; 29(34):5038-5053. PubMed ID: 37753370
[TBL] [Abstract] [Full Text] [Related]
5. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract] [Full Text] [Related]
6. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract] [Full Text] [Related]
7. Function of TRPC1 in modulating hepatocellular carcinoma progression.
Qi H; Wu F; Wang H
Med Oncol; 2023 Feb; 40(3):97. PubMed ID: 36797544
[TBL] [Abstract] [Full Text] [Related]
8. HHLA2 Immune Checkpoint Is a Novel Prognostic Predictor in Hepatocellular Carcinoma.
Liao X; Zhang D
Am J Clin Pathol; 2022 Jul; 158(1):62-69. PubMed ID: 35084443
[TBL] [Abstract] [Full Text] [Related]
9. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
[TBL] [Abstract] [Full Text] [Related]
10. Quantitative acetylome analysis reveals histone modifications that may predict prognosis in hepatitis B-related hepatocellular carcinoma.
Chai X; Guo J; Dong R; Yang X; Deng C; Wei C; Xu J; Han W; Lu J; Gao C; Gao D; Huang C; Ke A; Li S; Li H; Tian Y; Gu Z; Liu S; Liu H; Chen Q; Liu F; Zhou J; Fan J; Shi G; Wu F; Cai J
Clin Transl Med; 2021 Mar; 11(3):e313. PubMed ID: 33783990
[TBL] [Abstract] [Full Text] [Related]
11. Predicting the prognosis of hepatocellular carcinoma with the treatment of transcatheter arterial chemoembolization combined with microwave ablation using pretreatment MR imaging texture features.
Liu J; Pei Y; Zhang Y; Wu Y; Liu F; Gu S
Abdom Radiol (NY); 2021 Aug; 46(8):3748-3757. PubMed ID: 33386449
[TBL] [Abstract] [Full Text] [Related]
12. Downregulation of histone methyltransferase SET8 inhibits progression of hepatocellular carcinoma.
Wu J; Qiao K; Du Y; Zhang X; Cheng H; Peng L; Guo Z
Sci Rep; 2020 Mar; 10(1):4490. PubMed ID: 32161353
[TBL] [Abstract] [Full Text] [Related]
13. Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma.
Guo Z; Jia J; Yao M; Kang J; Wang Y; Yan X; Zhang L; Lv Q; Chen X; Lu F
Exp Cell Res; 2018 Dec; 373(1-2):211-220. PubMed ID: 30399372
[TBL] [Abstract] [Full Text] [Related]
14. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract] [Full Text] [Related]
15. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.
Tian H; Ge C; Zhao F; Zhu M; Zhang L; Huo Q; Li H; Chen T; Xie H; Cui Y; Yao M; Li J
Carcinogenesis; 2017 Feb; 38(2):207-217. PubMed ID: 27993894
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases.
Qian Y; Sang Y; Wang FX; Hong B; Wang Q; Zhou X; Weng T; Wu Z; Zheng M; Zhang H; Yao H
Oncotarget; 2016 Nov; 7(44):72242-72249. PubMed ID: 27750217
[TBL] [Abstract] [Full Text] [Related]
18. liver epithelial cells inhibit proliferation and invasiveness of hepatoma cells.
Jeng KS; Jeng CJ; Jeng WJ; Sheen IS; Li SY; Hung ZH; Hsiau HI; Yu MC; Chang CF
Oncol Rep; 2016 Mar; 35(3):1622-8. PubMed ID: 26647726
[TBL] [Abstract] [Full Text] [Related]
19. Circulating B7-H4 in serum predicts prognosis in patients with hepatocellular carcinoma.
Zhang SA; Wu ZX; Zhang X; Zeng ZY; Li DL
Genet Mol Res; 2015 Oct; 14(4):13041-8. PubMed ID: 26505457
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic value of serum B7-H4 for hepatocellular carcinoma.
Zhang C; Li Y; Wang Y
J Surg Res; 2015 Aug; 197(2):301-6. PubMed ID: 25963168
[TBL] [Abstract] [Full Text] [Related]
[Next]
